Kuldeep Singh Rajput, PhD
Biofourmis, Boston, Massachusetts, USA

Kuldeep Singh Rajput is the CEO and Founder of Boston-based Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care. Biofourmis' wearable sensor, remote monitoring and artificial intelligence-based predictive analytics are used to improve outcomes and lower costs in various therapeutic areas, including heart failure and other cardiometabolic conditions, oncology, pain, and most recently, infectious disease—specifically for COVID-19 monitoring. Biofourmis is pioneering an entirely new category of digital health, with its clinically validated software-based therapeutics and wearables platform that provide better outcomes for patients, smarter engagement and tracking tools for clinicians, technology to complement and demonstrate the value of pharmacotherapy, and cost-effective solutions for payers. In 2020, Biofourmis was named by Forbes as one of America’s Most Promising Artificial Intelligence Companies.